Suchergebnisse - "Winskill, Carolyn"

PubPharm (11)

1

Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment

enthalten in: The Journal of investigative dermatology | 2023

von Jour, G. | Illa-Bochaca, I. | Ibrahim, M. | +11

2

Predictors of Women's Intentions to Communicate Updated Genetic Test Results to Immediate and Extended Family Members

enthalten in: Public health genomics | 2023

von Winskill, C. | Goodman, M. | Daly, B. | +5

3

Effect of Anti-VEGF Therapy on the Disease Progression of Neovascular Age-Related Macular Degeneration : A Systematic Review and Model-Based Meta-Analysis

enthalten in: Journal of clinical pharmacology | 2022

von Luu, K. | Seal, J. | Green, M. | +2

4

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis

enthalten in: Frontiers in pediatrics | 2022

von Golhen, K. | Winskill, C. | Yeh, C. | +3

5

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis

enthalten in: Frontiers in medicine | 2022

von Golhen, K. | Winskill, C. | Theiler, M. | +5

6

Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration : A Systematic Review and Model‐Based Meta‐Analysis

enthalten in: The Journal of Clinical Pharmacology | 2022

von Luu, K. | Seal, J. | Green, M. | +2

7

Correction to : Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials

enthalten in: Pediatric rheumatology online journal | 2021

von Welzel, T. | Winskill, C. | Zhang, N. | +2

ErratumFor: Pediatr Rheumatol Online J. 2021 Mar 25;19(1):46. - PMID 33766063

8

Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

enthalten in: Pediatric rheumatology | 2021

von Welzel, T. | Winskill, C. | Zhang, N. | +2

9

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials

enthalten in: Pediatric rheumatology online journal | 2021

von Welzel, T. | Winskill, C. | Zhang, N. | +2

ErratumIn: Pediatr Rheumatol Online J. 2021 Aug 16;19(1):124. - PMID 34399784

10

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

enthalten in: Pediatric rheumatology | 2021

von Welzel, T. | Winskill, C. | Zhang, N. | +2